Addition of Macrolide Antibiotics for Hospital Treatment of Community-Acquired Pneumonia
At a population level, the addition of macrolides was not associated with improved clinical outcomes for patients with CAP. The potential benefits of additional macrolides should be weighed against the risks of adverse effects and anti-microbial resistance.
Authors
- A. Sarah Walker (ORCID: https://orcid.org/0000-0002-0412-8509)
- Jia Wei (ORCID: https://orcid.org/0000-0001-9621-529X)
- David W. Eyre (ORCID: https://orcid.org/0000-0001-5095-6367)
Institutions
- John Radcliffe Hospital (GB)
- Open Data Institute (GB)
- National Institute for Health and Care Research (GB)
- University of Oxford (GB)
- Oxford Biomedical Research (US)
- Nuffield Health (GB)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1093/infdis/jiae639
- Citations
- 11
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 4.25
Funders
- National Institute for Health Research Health Protection Research Unit
- National Institute for Health and Care Research
- University of Oxford
- NIHR Oxford Biomedical Research Centre